2014Journal of Pharmaceutical Research InternationalOpen access

Review of Drug Interactions: A Comprehensive Update

Madhav Mutalik

Open full text 5 citations

Abstract

Prescribing multiple medications predisposes to possibilities of occurrence of drug interactions. Various different terminology and ways exist to classify or arrange drug interactions. Drugs interact with other drugs, foods, beverages and herbs; outside or inside the body. Knowledge of In vitro interactions is essential to avoid loss of activity of drugs before administration. Although every theoretical drug interaction may not manifest in practice, drug interaction is a prominent cause of adverse or undesired events related to drug administration. Amongst the herbs, St. John’s wort has a potential of producing significant drug interactions due to its capacity to induce metabolism of number of drugs. In vivo interactions at pharmacokinetic level affect absorption, distribution, biotransformation or excretion of drugs. Induction or inhibition of cytochrome P450 (CYP450) enzymes forms a major basis of drug interactions. Induction of metabolism of a substrate drug leads to treatment failure. Inhibition of metabolism leads to serious interactions by aggravating toxicity of substrate drugs. As compared to induction, inhibition is a fairly rapid process, and number of precipitant drugs which inhibit the metabolism is much more than that of inducers. Role of drug transporters, especially P-glycoprotein (P-gp), in causation of drug interactions is being increasingly identified. P-gp affects absorption, distribution and excretion, and hence plays a major role in pharmacokinetic drug interactions. Additionally, P-gp works hand in hand with CYP450 enzymes. In pharmacodynamic interactions, the drugs synergise or antagonise the effect at the level of target of action. Clinically beneficial and reparative drug interactions are explored to obtain useful drug combinations. Extensive research has led to development of a large number of In vitro and In vivo methods to detect and predict drug interactions. Appropriate awareness and knowledge of possible drug interactions is crucial in prevention of drug interactions and their consequences.

About this research paper

What this paper is about

Prescribing multiple medications predisposes to possibilities of occurrence of drug interactions. Various different terminology and ways exist to classify or arrange drug interactions. Drugs interact with other drugs, foods, beverages and herbs; outside or inside the body. Knowledge of In vitro interactions is essential to avoid loss of activity of drugs before administration. Although every theoretical drug interaction may not manifest in practice, drug interaction is a prominent cause of adverse or undesired events related to drug administration. Amongst the herbs, St. John’s wort has a potential of producing significant drug interactions due to its capacity to induce metabolism of number of drugs. In vivo interactions at pharmacokinetic level affect absorption, distribution, biotransformation or excretion of drugs. Induction or inhibition of cytochrome P450 (CYP450) enzymes forms a major basis of drug interactions. Induction of metabolism of a substrate drug leads to treatment failure. Inhibition of metabolism leads to serious interactions by aggravating toxicity of substrate drugs. As compared to induction, inhibition is a fairly rapid process, and number of precipitant drugs which inhibit the metabolism is much more than that of inducers. Role of drug transporters, especially P-glycoprotein (P-gp), in causation of drug interactions is being increasingly identified. P-gp affects absorption, distribution and excretion, and hence plays a major role in pharmacokinetic drug interactions. Additionally, P-gp works hand in hand with CYP450 enzymes. In pharmacodynamic interactions, the drugs synergise or antagonise the effect at the level of target of action. Clinically beneficial and reparative drug interactions are explored to obtain useful drug combinations. Extensive research has led to development of a large number of In vitro and In vivo methods to detect and predict drug interactions. Appropriate awareness and knowledge of possible drug interactions is crucial in prevention of drug interactions and their consequences.

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Prescribing multiple medications predisposes to possibilities of occurrence of drug interactions. Various different terminology and ways exist to classify or arrange drug interactions. Drugs interact with other drugs, foods, beverages and herbs; outside or inside the body. Knowledge of In vitro interactions is essential to avoid loss of activity of drugs before administration. Although every theoretical drug interaction may not manifest in practice, drug interaction is a prominent cause of adverse or undesired events related to drug administration. Amongst the herbs, St. John’s wort has a potential of producing significant drug interactions due to its capacity to induce metabolism of number of drugs. In vivo interactions at pharmacokinetic level affect absorption, distribution, biotransformation or excretion of drugs. Induction or inhibition of cytochrome P450 (CYP450) enzymes forms a major basis of drug interactions. Induction of metabolism of a substrate drug leads to treatment failure. Inhibition of metabolism leads to serious interactions by aggravating toxicity of substrate drugs. As compared to induction, inhibition is a fairly rapid process, and number of precipitant drugs which inhibit the metabolism is much more than that of inducers. Role of drug transporters, especially P-glycoprotein (P-gp), in causation of drug interactions is being increasingly identified. P-gp affects absorption, distribution and excretion, and hence plays a major role in pharmacokinetic drug interactions. Additionally, P-gp works hand in hand with CYP450 enzymes. In pharmacodynamic interactions, the drugs synergise or antagonise the effect at the level of target of action. Clinically beneficial and reparative drug interactions are explored to obtain useful drug combinations. Extensive research has led to development of a large number of In vitro and In vivo methods to detect and predict drug interactions. Appropriate awareness and knowledge of possible drug interactions is crucial in prevention of drug interactions and their consequences.

Key concepts: Drug, Pharmacology, Drug interaction, Drug metabolism, Pharmacokinetics, Cytochrome P450, Pharmacodynamics, Drug action

Related papers

Back to paper searchBrowse research topicsOriginal source
Review of Drug Interactions: A Comprehensive Update — Research Paper | ScholarLens